Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Pediatrix Medical Group, Inc.'s quarterly P/E stands at 14.9x, down 1.6% year-over-year. EV/EBITDA has compressed 13.1% YoY to 10.4x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.12 | 14.85 | 13.37 | 4.99 | 7.97 | 15.09 | 9.37 | 12.60 | — | 50.15 | — | 12.22 | 10.45 |
| — | -1.6% | +42.7% | -60.4% | — | -69.9% | — | +3.1% | — | +128.7% | — | +9.6% | -36.3% | |
| P/S Ratio | 1.02 | 0.93 | 0.91 | 0.73 | 0.66 | 0.68 | 0.56 | 0.48 | 0.31 | 0.42 | 0.39 | 0.52 | 0.59 |
| — | +37.5% | +63.1% | +51.8% | +113.1% | +60.8% | +42.5% | -7.9% | -46.8% | -32.5% | -34.4% | -25.4% | -36.6% | |
| P/B Ratio | 2.32 | 2.02 | 2.09 | 1.61 | 1.49 | 1.58 | 1.47 | 1.34 | 0.89 | 0.98 | 0.92 | 1.09 | 1.25 |
| — | +28.3% | +41.6% | +20.4% | +67.9% | +61.5% | +60.0% | +22.8% | -28.6% | -27.7% | -33.4% | -31.6% | -41.4% | |
| P/FCF | 7.73 | — | 4.15 | 2.72 | 2.35 | — | 2.17 | 2.86 | 1.57 | — | 3.24 | 3.72 | 3.63 |
| — | — | +90.8% | -5.1% | +49.3% | — | -33.0% | -23.1% | -56.7% | — | -5.6% | -16.8% | -38.8% | |
| EV / EBITDA | 8.85 | 10.44 | 8.67 | 5.90 | 6.41 | 12.02 | 8.44 | 9.73 | — | 15.32 | — | 8.79 | 8.33 |
| — | -13.1% | +2.7% | -39.4% | — | -21.6% | — | +10.6% | — | +16.9% | — | -8.8% | -26.0% | |
| EV / EBIT | 9.69 | 11.81 | 9.62 | 4.78 | 6.52 | 12.08 | 9.06 | 11.03 | — | 21.79 | — | 10.56 | 9.87 |
| — | -2.2% | +6.2% | -56.7% | — | -44.6% | — | +4.4% | — | +28.1% | — | -6.0% | -23.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Pediatrix Medical Group, Inc.'s operating margin was 9.8% in Q1 2026, down 1.3 pp QoQ and up 2.8 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 11.9% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.7% | 22.4% | 24.4% | 28.5% | 26.6% | 22.4% | 25.6% | 22.9% | 22.6% | 19.2% | 20.4% | 21.1% | 23.1% |
| — | +0.2% | -4.7% | +24.6% | +17.6% | +16.9% | +25.5% | +8.3% | -1.9% | -4.0% | -9.6% | -10.3% | -10.6% | |
| Operating Margin | 12.1% | 9.8% | 11.1% | 13.8% | 12.8% | 7.0% | 7.8% | 6.6% | -31.3% | 3.2% | -22.5% | 7.9% | 9.7% |
| — | +39.7% | +41.6% | +108.6% | +140.8% | +118.2% | +134.8% | -16.8% | -422.8% | -47.5% | -420.2% | -17.8% | -6.1% | |
| Net Margin | 8.6% | 6.2% | 6.8% | 14.5% | 8.4% | 4.5% | 6.1% | 3.8% | -30.3% | 0.8% | -25.0% | 4.2% | 5.6% |
| — | +37.3% | +12.4% | +282.5% | +127.6% | +455.1% | +124.2% | -9.9% | -637.1% | -71.8% | -533.7% | -32.7% | +1.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 20.3% | 3.4% | 3.8% | 8.3% | 4.8% | 2.7% | 4.1% | 2.7% | -19.6% | 0.5% | -13.7% | 2.2% | 3.1% |
| — | +27.0% | -5.8% | +207.8% | +124.7% | +463.9% | +129.8% | +20.7% | -741.3% | -70.0% | -503.7% | -37.9% | -3.1% | |
| ROA | 7.5% | 1.4% | 1.5% | 3.3% | 1.9% | 1.0% | 1.4% | 1.0% | -7.4% | 0.2% | -5.5% | 0.9% | 1.2% |
| — | +37.0% | +5.1% | +249.2% | +126.1% | +443.9% | +126.4% | +3.4% | -701.1% | -69.8% | -531.4% | -29.3% | +6.1% | |
| ROIC | 14.8% | 2.8% | 3.5% | 4.2% | 3.4% | 1.9% | 2.3% | 1.9% | -7.9% | 0.8% | -5.3% | 1.8% | 2.1% |
| — | +50.4% | +49.0% | +121.4% | +143.9% | +146.6% | +144.0% | +3.9% | -468.0% | -43.3% | -422.4% | -14.2% | -2.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Pediatrix Medical Group, Inc.'s Debt/EBITDA ratio is 11.9x, up from 10.9x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 26.9% YoY to 1.33x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.72 | 0.76 | 0.72 | 0.78 | 0.83 | 0.87 | 0.93 | 0.99 | 0.91 | 0.83 | 0.73 | 0.79 |
| — | -13.7% | -11.9% | -22.7% | -21.2% | -8.7% | +4.8% | +27.8% | +24.9% | +0.6% | +2.8% | -23.0% | -23.2% | |
| Debt / EBITDA | 2.61 | 11.95 | 10.95 | 8.73 | 9.97 | 17.51 | 14.35 | 17.06 | — | 29.72 | — | 14.29 | 12.98 |
| — | -31.7% | -23.7% | -48.8% | — | -41.1% | — | +19.4% | — | +40.9% | — | -1.1% | -12.1% | |
| Current Ratio | 1.66 | 1.33 | 1.66 | 1.83 | 1.80 | 1.81 | 1.47 | 1.42 | 1.38 | 1.72 | 1.24 | 1.20 | 1.24 |
| — | -26.9% | +12.9% | +29.0% | +29.9% | +5.2% | +18.5% | +18.0% | +11.4% | +20.0% | +24.0% | -0.4% | -10.9% | |
| Quick Ratio | 1.66 | 1.33 | 1.66 | 1.83 | 1.80 | 1.81 | 1.47 | 1.42 | 1.38 | 1.72 | 1.24 | 1.20 | 1.24 |
| — | -26.9% | +12.9% | +29.0% | +29.9% | +5.2% | +18.5% | +18.0% | +11.4% | +20.0% | +24.0% | -0.4% | -10.9% | |
| Interest Coverage | 7.02 | 5.64 | 6.22 | 29.70 | 7.02 | 4.07 | 4.43 | 3.49 | -15.27 | 1.74 | -12.77 | 3.97 | 4.32 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MD stock.
Pediatrix Medical Group, Inc.'s current P/E is 12.1x. The average P/E over the last 4 quarters is 10.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Pediatrix Medical Group, Inc.'s current operating margin is 12.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Pediatrix Medical Group, Inc.'s business trajectory between earnings reports.